Canada on Saturday blocked bulk exports of pharmaceuticals if they might create a scarcity at house, in response to outgoing US President Donald Trump’s efforts to permit imports from Canada to decrease some drug costs for Individuals.
“Certain drugs intended for the Canadian market are prohibited from being distributed for consumption outside of Canada if that sale would cause or worsen a drug shortage,” Well being Minister Patty Hajdu stated in an announcement.
“Companies will now also be required to provide information to assess existing or potential shortages, when requested, and within 24 hours if there is a serious or imminent health risk,” the assertion stated.
The Canadian measure went into impact on Friday, simply days earlier than a U.S. “Importation Prescription Drugs” rule that might finally permit licensed U.S. pharmacists or wholesalers to import in bulk sure pharmaceuticals meant for the Canadian market.
Neither the White Home nor the Division of Well being and Human Companies had a direct response to a request for remark.
Trump touted the plan in his first debate with President-elect Joe Biden, who has additionally stated throughout his marketing campaign that he would arrange an analogous import plan to attempt to cut back prescription drug prices for Individuals.
“Canada is a small market, representing 2% of global drug sales, that sources 68% of its drugs internationally. The need for vigilance in maintaining the national drug supply continues,” the assertion stated.
Canadian Prime Minister Justin Trudeau stated in September he was keen to assist different nations with pharmaceutical provides if doable, including that his precedence was defending the wants of Canadians.
A lot of Canada’s drug suppliers opposed Trump’s plan, saying it may result in shortages.